Enanta Pharmaceuticals, Inc.
ENTANASDAQHealthcare● Active
$11.07
$-0.21(-1.86%)
Market Cap$257008172
P/E Ratio—
52W High$17.15
52W Low$6.435
Enanta Pharmaceuticals, Inc.（ENTA）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ENTA · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-09 | 2024-09 | 2023-09 | 2022-09 | 2021-09 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $65.32M | $67.64M | $79.20M | $86.16M | $97.07M |
| Cost of Revenue | $4.59M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $60.74M | $67.64M | $79.20M | $86.16M | $97.07M |
| Gross Margin %(computed) | 92.98% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $106.74M | $131.48M | $163.52M | $164.52M | $174.11M |
| G&A Expenses | $43.93M | $57.85M | $52.89M | $45.48M | $32.54M |
| Total Operating Expenses | $146.09M | $189.33M | $216.41M | $210.00M | $206.65M |
| Operating Income | ($85.35M) | ($121.69M) | ($137.21M) | ($123.84M) | ($109.57M) |
| Operating Margin %(computed) | -130.65% | -179.92% | -173.23% | -143.74% | -112.88% |
| Interest Income | $9.48M | $14.77M | $11.36M | $1.57M | $2.02M |
| Interest Expense | $7.68M | $10.94M | $5.15M | $0.00M | $0.00M |
| Income Before Tax | ($83.55M) | ($117.79M) | ($131.00M) | ($122.19M) | ($107.58M) |
| Income Tax Expense | ($1.66M) | ($1.74M) | $2.82M | ($0.43M) | ($28.58M) |
| Net Income | ($81.89M) | ($116.05M) | ($133.82M) | ($121.75M) | ($79.00M) |
| Net Margin %(computed) | -125.36% | -171.58% | -168.95% | -141.31% | -81.38% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.84 | $-5.48 | $-6.38 | $-5.91 | $-3.92 |
| Wtd Avg Shares | 21.34M | 21.16M | 20.97M | 20.60M | 20.17M |
| EBITDA | ($70.78M) | ($104.51M) | ($123.48M) | ($119.22M) | ($104.25M) |
| EBITDA Margin %(computed) | -108.35% | -154.52% | -155.90% | -138.36% | -107.39% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Enanta Pharmaceuticals, Inc.
关于Enanta Pharmaceuticals, Inc.（ENTA）损益表
Enanta Pharmaceuticals, Inc.（ENTA）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，ENTA实现营收$0.07B，毛利润$0.06B（毛利率92.98%），净利润($0.08B)（净利率-125.36%）。
常见问题
ENTA · 4 问Enanta Pharmaceuticals, Inc.（ENTA）2025财年营收为$0.07B，同比down3.4%。
ENTA revenueENTA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08